Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

In the upside-down world of Health and Human Services Secretary Robert F. Kennedy Jr., vaccines are on the ropes.

The Allan Labor Government is supporting Melbourne researchers who have discovered a groundbreaking RNA treatment targeting rare childhood diseases ...

Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Physician and science communicator Kristen Panthagani talks about why public trust in vaccines has fallen since the COVID-19 ...

Semiliquid funds bypass capital calls and drawdown delays, giving investors direct exposure to private markets while ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing novel immunotherapies and vaccines for solid tumor cancers and infectious diseases, today announced the publication ...

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the future of vaccine regulation in the U.S. — and could have profound ...